Angle-Closure Glaucoma and Glaucoma Genetics Research Group
Prof Aung Tin
My research focuses on angle-closure glaucoma (ACG) and glaucoma genetics. Our work is dedicated to uncovering the mechanisms underlying primary angle-closure glaucoma (PACG), a major form of glaucoma and cause of blindness in Asia, and developing improved strategies for its prevention and treatment. Our research group is currently conducting large-scale studies on the epidemiology, risk factors, imaging, clinical phenotypes, genetics and management of PACG. By utilizing advanced imaging technologies, we aim to identify novel biomarkers and mechanisms that enable earlier detection and more effective interventions. Additionally, we are exploring the genetic contributors to PACG by analyzing extensive datasets from whole exome sequencing, with the goal of discovering critical genes involved in the disease's development.
In the broader field of glaucoma genetics, our group is leading international collaborations to uncover genetic loci associated with various forms of glaucoma, including PACG, exfoliation glaucoma, and open-angle glaucoma. Through extensive genome-wide association studies (GWAS), whole exome sequencing (WES), and partnerships with global consortia, we aim to enhance diagnostic tools, deepen insights into disease mechanisms, and determine the biology of newly discovered gene(s) as potential therapeutic targets with the goal for direct clinical application.
Ocular Imaging Research Group
Prof Leopold Schmetterer
Figure 2. Demonstration of using normative capillary perfusion maps in quantifying capillary defects in glaucoma eyes. A,E) Visual fields. B,F) grayscale 12x12 mm2 OCT angiography images C,G) capillary perfusion maps, D,H) visualisation of the loci and severities of the capillary defects in glaucoma eyes.
We are developing novel imaging devices aimed to improve diagnosis and follow up of glaucoma patients. These devices are based on optical coherence tomography (OCT) and aim to obtain meaningful parameters that are related to the disease processes.
Examples include OCT angiography to visualise the retinal and choroidal capillary network, polarisation-sensitive OCT to measure birefringence of tissue, hyperspectral OCT to detect abnormal scattering and absorption of injured ganglion cells and OCT-based opto-physiology to study intrinsic signals from retinal neurons in response to light stimulation.
In addition, we are interested in structure /function relationship in glaucoma for improved follow up as well as novel analysis technique for OCT images using both multi-regression models and AI-based approaches.
Deep Phenotyping and Genetic Landscaping of Primary Open Angle Glaucoma
Prof Cheng Ching-Yu
We aim to establish a large-scale DNA biobank for primary open angle glaucoma (POAG), linking rich glaucoma functional and structural phenotypic data, to comprehensively characterise the genetic profiles of this disease.
We will achieve this using state-of-the-art ocular imaging and systematic characterisation of low-frequency coding variants underlying POAG through whole-exome sequencing. The discovery of protein-changing mutations will revolutionise the field of glaucoma genetics and may lead to the development of genetic tests for high-risk individuals who will benefit from timely interventions to slow the rate of disease progression of disease or open new avenues for drug targets. This will facilitate precision medicine, tailoring treatment or prevention strategies according to individuals’ unique characteristics.
Neurovascular Dysfunction in Glaucoma
Dr Rachel Chong
Many glaucoma patients continue to suffer sight-loss despite the clinician’s best efforts to lower their intraocular pressure. Recent research points to a close relationship between nerve cells and vascular cells that provide oxygen and nutrients to support important neuronal connections. We aim to understand how the eye regulates blood flow internally despite changes in eye pressure and factors that influence systemic blood pressure. Our lab focuses on real time, dynamic changes that occur in preclinical models of glaucoma through the use of specialised imaging devices. I also have an interest in the relationship between high myopia and glaucoma, and run a dedicated service for this high risk group of patients. We are exploring novel methods of improving the management of this type of glaucoma that frequently poses a diagnostic challenge, through novel approaches to monitoring changes in neuronal and vascular markers in the eye.
Translational Ophthalmic Pathology Research Platform
Dr Anita Chan
Our platform focuses on experimental glaucoma models (Figure 5) and harnesses our pathology expertise to study the ultrastructural changes using electron microscopy (Figure 6) and histological structural changes (Figure 5) that occur because of an increased eye pressure on the optic nerve and retina. We then correlate this with our clinical in vivo imaging so we can translate this to clinical care.
We then study the role of various drugs and interventions to see if we can delay and even prevent these changes and thus the progression of glaucoma. Our experimental glaucoma models include open angle glaucoma as well as a primary angle closure model which allows us to comprehensively study and evaluate novel therapies for the more common types of glaucoma in Singapore and in the world.
Research Team
| Name |
Designation |
| Prof Aung Tin | Senior Consultant, SNEC |
| Prof Jonathan Crowston | Senior Consultant, SNEC |
| Prof Tina Wong | Head & Senior Consultant, SNEC |
| Assoc Prof Shamira Perera | Senior Consultant, SNEC |
| Clin Assoc Prof Rahat Husain | Senior Consultant, SNEC |
| Clin Assoc Prof Ho Ching Lin | Senior Consultant, SNEC |
| Assoc Prof Boey Pui Yi | Senior Consultant, SNEC |
| Dr Annabel Chew | Senior Consultant, SNEC |
| Dr Anita Chan | Senior Consultant, SNEC |
| Dr Rachel Chong | Consultant, SNEC |
| Dr Yap Zhu Li | Consultant, SNEC |
| Dr Fiona Lim | Consultant, SNEC |
| Dr Olivia Huang | Consultant, SNEC |
| Dr Ng Si Rui | Consultant, SNEC |
| Dr Kiew Sieh Yean | Consultant, SNEC |
| Dr Low Jin Rong | Consultant, SNEC |
| Dr Lee Yi Fang | Associate Consultant, SNEC |
| Dr Reuben Foo | Associate Consultant, SNEC |
| Assoc Prof Michael Girard | Co-Head, Bioengineering & Devices Research Group |
| Prof Cheng Ching-Yu | Head, Ocular Epidemiology Research Group |
| Prof Leopold Schmetterer | Head, Ocular Imaging Research Group |
| Assoc Prof Monisha Esther Nongpiur | Clinician Scientist |
| Dr Katharina Bell | Senior Clinical Research Fellow I |
| Dr Natalia Porporato | Clinical Research Fellow II |
| Dr Tin Aung Tun | Research Fellow |
Research Optometrists/ Coordinators/ Assistants
| Name |
Designation |
| Stella Ng | Assistant Manager |
| Fong Yee Wei | Lead Clinical Research Coordinator |
| Teo Soh Chin | Senior Clinical Research Coordinator |
| Ooi Ya Ying | Senior Clinical Research Coordinator |
| Anna Sim | Senior Clinical Research Coordinator |
| Cheryl Tan | Senior Clinical Research Coordinator |
| Sheryl Soo | Clinical Research Coordinator I |
| Gao Fei | Clinical Research Coordinator I |